Malaysian Agency Plans New Regs On Medical Device Recalls
This article was originally published in PharmAsia News
The Malaysian Medical Device Authority is planning a new draft guideline that explains the processes that medical device companies should put in place to initiate a voluntary product recall, or to deal with a recall ordered by the regulator.
You may also be interested in...
While inspection interviews can be stressful for drug firms, a Dutch pharmacovigilance inspector reassures companies that any responses made during the process cannot undo any good work they have already done. And they can also correct any wrong answers later on.
The Saudi Food & Drug Authority looks at the number of individual case safety reports (ICSRs) submitted by a company, among other risk-based factors, when drawing up its list for routine pharmacovigilance inspections.
Based on its experience of reviewing tools used by companies for additional risk minimization, the European Medicines Agency is planning to update its guidance on this topic with more information on how these tools can be better employed.